In My Opinion Elanco's rejection of the option agreement had nothing to do with the amount of dogs in the trial, it was about show me the money honey. Elenco have been offered a licencing agreement, but what they want is a part ownership of our patients covering all the stuff PAA has patents on, check 70 reasons thread.
In the long run we the shareholders of PAA will come out in front. Elanco's patents start to run out next year and if the covid19 thing turns out in our favour an agreement will have global forces on it . 50-50 would be ok with me. All in my opinion only
I have faith in our BoD
Good Luck To All
PAA Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)